These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. Rohan LC; Moncla BJ; Kunjara Na Ayudhya RP; Cost M; Huang Y; Gai F; Billitto N; Lynam JD; Pryke K; Graebing P; Hopkins N; Rooney JF; Friend D; Dezzutti CS PLoS One; 2010 Feb; 5(2):e9310. PubMed ID: 20174579 [TBL] [Abstract][Full Text] [Related]
13. Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides. Neurath AR; Strick N; Li YY BMC Infect Dis; 2006 Oct; 6():150. PubMed ID: 17042959 [TBL] [Abstract][Full Text] [Related]
14. A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models. Berzi A; Reina JJ; Ottria R; Sutkeviciute I; Antonazzo P; Sanchez-Navarro M; Chabrol E; Biasin M; Trabattoni D; Cetin I; Rojo J; Fieschi F; Bernardi A; Clerici M AIDS; 2012 Jan; 26(2):127-37. PubMed ID: 22045343 [TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5. Kish-Catalone TM; Lu W; Gallo RC; DeVico AL Antimicrob Agents Chemother; 2006 Apr; 50(4):1497-509. PubMed ID: 16569870 [TBL] [Abstract][Full Text] [Related]
16. Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection. Liu S; Lu H; Neurath AR; Jiang S Antimicrob Agents Chemother; 2005 May; 49(5):1830-6. PubMed ID: 15855503 [TBL] [Abstract][Full Text] [Related]
18. Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Catalone BJ; Kish-Catalone TM; Budgeon LR; Neely EB; Ferguson M; Krebs FC; Howett MK; Labib M; Rando R; Wigdahl B Antimicrob Agents Chemother; 2004 May; 48(5):1837-47. PubMed ID: 15105142 [TBL] [Abstract][Full Text] [Related]
19. A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides. Van Herrewege Y; Michiels J; Waeytens A; De Boeck G; Salden E; Heyndrickx L; van den Mooter G; de Béthune MP; Andries K; Lewi P; Praet M; Vanham G Antiviral Res; 2007 May; 74(2):111-24. PubMed ID: 17097156 [TBL] [Abstract][Full Text] [Related]
20. Use of frozen-thawed cervical tissues in the organ culture system to measure anti-HIV activities of candidate microbicides. Gupta P; Ratner D; Patterson BK; Kulka K; Rohan LC; Parniak MA; Isaacs CE; Hillier S AIDS Res Hum Retroviruses; 2006 May; 22(5):419-24. PubMed ID: 16706618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]